Psychosocial Intervention for Dementia Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist caregivers of relatives with Alzheimer's or related dementia (ADRD) by providing support through counseling and social media chat groups. It focuses on Chinese and Korean American caregivers in New York City and Bergen County, New Jersey. The study will test whether these interventions, known as the NYU Caregiver Intervention-Enhanced Support (NYUCI-ES), reduce stress, depression, and health risks associated with heart disease and other metabolic conditions. Eligible participants are primary family caregivers with conditions like high blood pressure or diabetes who assist relatives with memory issues. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance caregiver support and well-being.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on providing support and education rather than changing medication regimens.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the New York University Caregiver Intervention (NYUCI) is safe for individuals. Studies have found that this program not only reduces stress and burden for dementia caregivers but also improves their mental and physical health. This is crucial because stress can harm the body and mind over time. The NYUCI has been successfully applied to various groups, including Asian-American caregivers, demonstrating its effectiveness across different cultures.
Reports do not mention any serious negative effects from the NYUCI. Instead, caregivers report greater satisfaction with social support and experience less family conflict. These positive outcomes suggest that the program is both safe and beneficial for participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it offers a comprehensive approach to supporting dementia caregivers, which is different from the usual support options like basic counseling or informational sessions. This treatment uniquely combines structured counseling sessions, local support group participation, and flexible "ad hoc" counseling to address the emotional and practical challenges caregivers face. By integrating various support methods, this approach aims to provide more personalized and immediate relief, potentially improving the overall well-being of caregivers more effectively than existing options.
What evidence suggests that the NYUCI-ES intervention could be effective for dementia caregivers?
In this trial, participants in the Treatment Group will receive the NYU Caregiver Intervention with Enhanced Support (NYUCI-ES). Research shows that this intervention reduces stress and improves well-being for those caring for someone with dementia. In past studies, caregivers in this program felt less depressed and stressed. The program also reduces the likelihood of caregivers needing to move their loved ones into nursing homes. This means the program not only supports caregivers' mental health but also enhances their caregiving skills. For Asian American caregivers, adjusting the program to fit cultural needs may increase its effectiveness. Meanwhile, participants in the Control Group will join an online chat group and have access to a counselor for resource information and support as needed.12678
Who Is on the Research Team?
Bei Wu, PhD
Principal Investigator
New York University
Are You a Good Fit for This Trial?
This trial is for older Chinese and Korean American adults (50+) in New York or Bergen County, NJ who are primary caregivers for relatives with dementia. They must have internet access, read English/Chinese/Korean, and meet certain health criteria like diabetes or high cholesterol but not be dealing with substance abuse or recent psychiatric hospitalizations.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the NYUCI-ES intervention, including 6 counseling sessions, participation in local support groups, and online chat groups
Follow-up
Participants are monitored for psychosocial and biological health outcomes, including hypertension, depressive symptoms, and chronic disease management
What Are the Treatments Tested in This Trial?
Interventions
- Treatment Group
Treatment Group is already approved in United States for the following indications:
- Psychosocial support for ADRD caregivers
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York University
Lead Sponsor
NYU Langone Health
Collaborator
Rutgers University
Collaborator